The maturation of markets such as pharmaceuticals, medical devices and diagnostics means that superior strategic marketing skills are now a necessary precondition for competitive advantage in those markets. This paper uses extensive prior research and original empirical work to characterise ‘Marketing Excellence’ and the organisational conditions that are the precursors to achieving it.
GrabowskiH.VernonJ. (1982). A sensitivity analysis of expected profitability of pharmaceutical research and development. Manage. Decis. Econ.3(1), 36–40.
2.
LynchR. L. (1997). Corporate Strategy (1st edn) Pitman, London.
3.
CamillusJ. C. (1984). Technology-driven and market driven life cycles: Implications for multinational corporate strategy. Columbia J. World Bus.19(2), 56–60.
4.
AnsoffI. H. (1965). Corporate Strategy, Penguin, London.
5.
LeiD.SlocumJ. W.Jr (2005). Strategic and organizational requirements for competitive advantage. Acad. Manage. Exec.19(1), 31–45.
6.
IMS Health (2006). Pharmaceutical industry sales amd new product introductions data.
7.
SmithB. D. (2003). The effectiveness of marketing strategy making processes in medical markets. PhD, Cranfield School of Management.
8.
KotlerP. (2002). Marketing Management (11th edn), Pearson, New York.
9.
McDonaldM. H. (2002). Marketing Plans: How to Prepare Them, How to Use Them (5th edn), Butterworth Heinemann, Oxford.
HillT.WestbrookR. (1997). SWOT analysis: It's time for a product recall. Long Range Plan. 30(1), 46–52.
15.
SmithB. D. (2003). An empirical investigation of marketing strategy quality in medical markets. Int. J. Med. Market. 3(2), 153–162.
16.
NeelyA.Al NajjarM. (2006). Management learning not management control: The true role of performance measurement. California Manage. Rev.48(3), 99–114.
17.
TippinsM. J.SohiR. S. (2003). IT competence and firm performance: Is organisational learning a missing link. Strategic Manage. J.24, 745–761.
18.
TourishD.RobsonP. (2006). Sensemaking and distortion of critical upward communication in organisations. J. Manage. Stud.43(4), 711–731.
19.
SmithB. D. (2003). The effectiveness of marketing strategy making processes: A critical literature review and a research agenda. J. Target. Measure. Anal. Market. 11(3), 273–290.
20.
SmithB. D. (2003). Success and failure in marketing strategy making: Results of an empirical study across medical markets. Int. J. Med. Market. 3(4), 287–315.
21.
SmithB. D. (2003). Making marketing happen: How great medical companies make strategic marketing planning work for them. Int. J. Med. Market. 4(2), 129–142.
22.
DooleyR. S.FryxellG. E.JudgeW. (2000). Belaboring the not-so-obvious: Consensus, commitment and strategy implementation speed and success. J. Manage. 26(6), 1237–1257.
23.
SchonD. A. (1999). The Reflective Practitioner: How Professionals Think in Action (1st edn), Perseus Books Group, New York.
24.
ArgyrisC.SchonD. A. (1978). Organisational Learning: A Theory in Action Perspective, Addison-Wesley, Reading MA.
25.
SmithB. D. (2006). In theory. Pharmaceutical Marketing Europe, 26th March, 24–26.
